BRPI0410026A - derivados de 3-amino-croman quinolina - Google Patents

derivados de 3-amino-croman quinolina

Info

Publication number
BRPI0410026A
BRPI0410026A BRPI0410026-3A BRPI0410026A BRPI0410026A BR PI0410026 A BRPI0410026 A BR PI0410026A BR PI0410026 A BRPI0410026 A BR PI0410026A BR PI0410026 A BRPI0410026 A BR PI0410026A
Authority
BR
Brazil
Prior art keywords
amino
chroman
quinoline derivatives
compounds
compositions containing
Prior art date
Application number
BRPI0410026-3A
Other languages
English (en)
Inventor
Nicole Theriault Hatzenbuhler
Dahui Zhou
Paul Gary Stack
Jonathan Laird Gross
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0410026A publication Critical patent/BRPI0410026A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE 3-AMINO-CROMAN QUINOLINA". A presente invenção refere-se a derivados de 3-amino-croman quinolina e composições contendo tais compostos. São descritos métodos para uso dos derivados de 3-amino-croman quinolina e composições contendo tais compostos no tratamento dos distúrbios da serotonina. São descritos também processos para preparação dos derivados de 3-amino-croman quinolina.
BRPI0410026-3A 2003-04-30 2004-04-30 derivados de 3-amino-croman quinolina BRPI0410026A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46658303P 2003-04-30 2003-04-30
US10/835,128 US7227023B2 (en) 2003-04-30 2004-04-29 Quinoline 3-amino chroman derivatives
PCT/US2004/013433 WO2004099214A1 (en) 2003-04-30 2004-04-30 Quinoline 3-amino chroman derivatives

Publications (1)

Publication Number Publication Date
BRPI0410026A true BRPI0410026A (pt) 2006-04-25

Family

ID=33436707

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410026-3A BRPI0410026A (pt) 2003-04-30 2004-04-30 derivados de 3-amino-croman quinolina

Country Status (9)

Country Link
US (2) US7227023B2 (pt)
EP (1) EP1638976A1 (pt)
JP (1) JP2006525350A (pt)
CN (1) CN100384849C (pt)
AU (1) AU2004236227A1 (pt)
BR (1) BRPI0410026A (pt)
CA (1) CA2523238A1 (pt)
MX (1) MXPA05011535A (pt)
WO (1) WO2004099214A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521771A (ja) * 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
BRPI0611948A2 (pt) * 2005-06-17 2010-10-13 Wyeth Corp compostos úteis como inibidores de serotonina e agonistas de antagonista de 5-ht1a
US20080139546A1 (en) * 2006-09-29 2008-06-12 Wyeth Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines
UA97837C2 (ru) 2007-03-23 2012-03-26 Эбботт Гмбх Унд Ко. Кг Соединения хинолина для лечения нарушений, которые реагируют на модуляцию рецептора серотонина 5-ht6
CL2008002693A1 (es) * 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510068B1 (en) 1990-01-11 1999-04-14 PHARMACIA & UPJOHN COMPANY NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS
WO1991013872A1 (en) 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
ATE195935T1 (de) 1993-03-25 2000-09-15 Upjohn Co Formyl- oder cyano- substituierte indolderivate mit dopaminergischer wirkung
AR004229A1 (es) 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
US6121307A (en) * 1998-04-08 2000-09-19 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
US7026484B2 (en) 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
US6903110B2 (en) 2001-07-25 2005-06-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
MXPA05006433A (es) 2002-12-20 2005-08-19 Merck Patent Gmbh Benzodioxepinas sustituidas.

Also Published As

Publication number Publication date
US20070191417A1 (en) 2007-08-16
CA2523238A1 (en) 2004-11-18
US20050004157A1 (en) 2005-01-06
CN1809574A (zh) 2006-07-26
AU2004236227A1 (en) 2004-11-18
US7227023B2 (en) 2007-06-05
JP2006525350A (ja) 2006-11-09
WO2004099214A1 (en) 2004-11-18
EP1638976A1 (en) 2006-03-29
WO2004099214A8 (en) 2006-05-04
MXPA05011535A (es) 2007-10-18
CN100384849C (zh) 2008-04-30

Similar Documents

Publication Publication Date Title
IS6520A (is) Ný efnasambönd
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
IS6658A (is) Ný efnasambönd
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
BRPI0406801B8 (pt) derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
SE0302139D0 (sv) Novel compounds
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
SE0003476D0 (sv) Compounds
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
EE05182B1 (et) Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
MXPA05011677A (es) Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina.
ATE274515T1 (de) Pyrazolopyridinderivate
SE0302755D0 (sv) Novel compounds
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
TW200504051A (en) Novel acridine derivatives and their use as medicaments

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.